Card image cap
INVO Bioscience Reports 2019 Financial Results

SARASOTA, Fla., March 30, 2020 -- INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alt

August 25, 2023
Card image cap
INVO Reports Second Quarter 2023 Financial Results

Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla., Aug. 14, 2023 -- INVO Bioscience, Inc. (Nasdaq: INVO

August 14, 2023
Card image cap
INVO Closes Acquisition of Wisconsin Fertility Institute

Transformational and accretive acquisition adds significant scale to INVO's current operations Contributes over $5 milli

August 11, 2023
Card image cap
INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023

Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET SARASOTA, Fla., Aug.

August 9, 2023
Card image cap
INVO Bioscience Announces Closing of $4.5 Million Public Offering

SARASOTA, Fla., Aug. 8, 2023 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services f

August 8, 2023
Card image cap
INVO Bioscience Announces Pricing of $4.5 Million Public Offering

SARASOTA, Fla., Aug. 4, 2023 -- INVO Bioscience, Inc. (Nasdaq:INVO) ("INVO" or the "Company"), a healthcare services fe

August 4, 2023
Card image cap
INVO Sets Revised Closing Date of Wisconsin Fertility Institute Acquisition and Announces Key Operational Trends to Drive Shareholder Value

Company sets closing date deadline of acquisition to August 10, 2023 -- Acquisition is expected to significantly enhance

August 3, 2023
Card image cap
INVO Announces a 1:20 Reverse Stock Split Effective Pre-Market Opening on July 28, 2023

SARASOTA, Fla., July 27, 2023 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fer

July 27, 2023
Card image cap
INVO Receives 510(k) FDA Clearance for Expanded Use of the INVOcell Device

INVOcell now cleared for 5-day incubation period Supporting data reflects improved patient outcomes, similar to IVF

June 28, 2023